510(k) Report

510(k) · Cleared

Recalled · 2008

Modification to Outback Catheter

K014117510(k) SpecialCleared Jan 11, 200228-day reviewClass II21 CFR 870.1250Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lumend, Inc. · DQY Catheter, Percutaneous

Cleared on Jan 11, 2002 as substantially equivalent to K001577 (Lumend, Inc., 2001) after a 28-day review. Its family tree reaches back 1 generation to 2001. 8 later devices descend from it. It has been recalled once.

Decided
Jan 11, 2002
Review
28 days
Class
Class II
Product code
DQY
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K001577 (2001). 8 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2004: 1 descendant cleared2005: 1 descendant cleared2009: 1 descendant cleared2015: 1 descendant cleared2013: 1 descendant cleared2022: 1 descendant cleared2025: 1 descendant clearedK001577 · Outback Catheter · Lumend, Inc. · 2001 · recalled200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 1 descendant4 generations forward: 2 descendants5 generations forward: 1 descendant6 generations forward: 1 descendant K001577 · Outback Catheter · Lumend, Inc. · 2001 · recalled0+5
  1. Root · 1 generation backK001577 Outback CatheterLumend, Inc. · 2001 · Recalled
  2. This deviceK014117 Modification to Outback CatheterLumend, Inc. · 2002
  3. Descendant · cites it directly · 7 of its ownK032298 Modification to Outback CatheterLumend, Inc. · 2003 · Recalled
  4. Descendant · 2 generations on · 6 of its ownK040771 Modification to Outback CatheterLumend, Inc. · 2004 · Recalled
  5. Descendant · 2 generations on · 5 of its ownK043534 Modification to Outback CatheterLumend, Inc. · 2005 · Recalled
  6. Descendant · 3 generations on · 4 of its ownK083814 Outback LTD RE-Entry Catheter, Model: OTB42120Cordis Corp., A Johnson & Johnson Co. · 2009
  7. Descendant · 4 generations on · 2 of its ownK150836 OUTBACK Elite Re-Entry CatheterCordis Corporation, A Johnson & Johnson Co. · 2015

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2003: 12004: 12005: 12009: 12013: 12015: 12022: 12025: 1
2003high 1 (2003) · low 0 (2006)2026

Most influential descendants

Showing 5 of 8 · See all
  • K032298Modification to Outback CatheterLumend, Inc. · 2003 · cites it directly7descendants
  • K040771Modification to Outback CatheterLumend, Inc. · 2004 · 2 generations on6descendants
  • K043534Modification to Outback CatheterLumend, Inc. · 2005 · 2 generations on5descendants
  • K083814Outback LTD RE-Entry Catheter, Model: OTB42120Cordis Corp., A Johnson & Johnson Co. · 2009 · 3 generations on4descendants
  • K150836OUTBACK Elite Re-Entry CatheterCordis Corporation, A Johnson & Johnson Co. · 2015 · 4 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K001577Outback CatheterLumend, Inc.20011
0 (this device)K014117Modification to Outback CatheterLumend, Inc.2002—
+1K032298Modification to Outback CatheterLumend, Inc.20032
+2K040771Modification to Outback CatheterLumend, Inc.20041
+2K043534Modification to Outback CatheterLumend, Inc.20051
+3K083814Outback LTD RE-Entry Catheter, Model: OTB42120Cordis Corp., A Johnson & Johnson Co.2009—
+4K150836OUTBACK Elite Re-Entry CatheterCordis Corporation, A Johnson & Johnson Co.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200410
200510
200910
201310
201510
202210
202510
FIG. 1 — Lineage of K014117, 2001–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K001577Outback Catheter
Summary page 1
…Percutaneous Catheter Classification: Class II Classification Name: Percutaneous Catheter, 21 CFR Part 870.1250 Product Code: 74DQY Predicate Device: Outback™ Catheter (K001577) Intended Use: The Outback Catheter is intended to facilitate placement and positioning of catheters within the peripheral vascu…
Lumend, Inc.20011

Also cleared against K001577: 4 other devices →

What descends from it? (8)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K032298Modification to Outback CatheterLumend, Inc.20037

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 20, 2008Not classifiedZ-0279-2009OtherThe Cordis LuMend Outback LTD Re-Entry Catheter - separation rate of the cannula to the deployment slide of the handle assembly is higher than anticipated. The cannula is unable to be retracted into the device after deployment due to a…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K032298 (Lumend, Inc., 2003) has gone furthest, with 7 descendants of its own.
  • 4 other devices also cite its predicate K001577.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The Outback Catheter is intended to facilitate placement and positioning of catheters within the peripheral vasculature. The Outback Catheter is not intended for use in the coronary or cerebral vasculature.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K014117: Modification to Outback Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K014117

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026